One of the many ways cells transmit information within their volume is through steady spatial gradients of different proteins. However, the mechanism through which such single-cell gradients form is not yet fully understood. We first demonstrate that one of the models for gradient formation, based on differential diffusion, is limited to proteins with large ratios of their diffusion constants or to specific protein-large molecule interactions. We then introduce an alternative for gradient formation via the coupling of the proteins within a single cell with a molecule whose action is similar to that of morphogens in multi-cell assemblies; the "morphogen" is produced with a fixed flux at one side of the cell. This coupling results in an effectively non-linear diffusion degradation model for the "morphogen" dynamics within the cell; it is the non-linearity that leads to a steady state gradient of the protein concentration. We use a stability analysis to show that these gradients are linearly stable with respect to perturbations.
I. INTRODUCTION
The spatial regulation of different active processes at various stages of development presents an intriguing problem of biological physics. A large number of recent observations suggest that intracellular as well as extracellular gradients of various biological molecules are one means of imparting spatial information over a range of length scales for different processes [1] [2] [3] [4] [5] [6] [7] . The initiation of mitosis in fission yeast [7] [8] [9] [10] , chromosome organization and DNA replication in bacteria [11, 12] , chemotaxis in Escherichia coli [13, 14] , germline formation in C. Elegans [15, 16] are some examples. It has also been shown that such gradients of morphogens or proteins are quite robust to perturbations [17, 18] and in some cases, may scale with the system size [19] [20] [21] [22] . Intuitively, one might guess that chemical signaling, in the form of a diffusing morphogen, must be involved in such processes. Indeed, it has been shown that different types of morphogens are involved in the gradient formation of various types of proteins [4] [5] [6] . However, there are other approaches such as differential diffusion that have been used to explain the formation of protein gradients within the cell. Given the diversity of proteins involved and the inherently nonequilibrium nature of the systems, it is unlikely that a single mechanism accounts for all systems.
Despite being one of the key processes for development of biological systems, the basic mechanism of how proteins form, such gradients is not yet completely understood. Apart from some kinetic modeling [4, 5] , most of our understanding for this problem comes from the differential diffusion model of two or more states (e.g., phosphorylation states) of the same protein that, for example, are introduced by localized source of phosphorylation (addition of phosphate group (P O 3− 4 )) and spatially uniform dephosphorylation [15, 23] . This can be generalized to other states of molecules. These models are crucially * Electronic address: saroj.nandi@weizmann.ac.il † Electronic address: sam.safran@weizmann.ac.il dependent on there being a relatively large difference in diffusivity of the protein upon phosphorylation. They are therefore limited to specific protein-large molecule associations, regulated by phosphorylation, that lead to an effectively much larger protein complex, since phosphorylation by itself does not significantly change the diffusivity of proteins [23, 24] . In the following section, we analyze these models and show their limitations which motivates the need for alternative mechanisms such as the one presented in this paper, which is based on the interactions of the proteins with gradients of molecules whose action within a single cell is similar to that of morphogens in cell assemblies.
An early model by Crick shows that freely diffusing morphogen produced at a source and degraded at a sink at a distant point produces a "linear" gradient at a biologically relevant time scale [25] . Although it is by now well-known that a "localized" sink is not necessary for gradient formation; uniform degradation throughout the systems can also result in molecular gradients [3] . In the case of some proteins, gradients can be formed by localized sources and sinks separated in space; this has been applied to the Bicoid protein in Drosophila embryos [26] [27] [28] . However, there are other types of proteins that form gradients without any cellular source or sink of the proteins themselves. We show in this paper that protein gradients may form if the proteins are coupled to other molecules that (in a generalization of terminology used in development) we denote as "morphogens" that act within a single-cell. [Morphogens are typically discussed in terms of development in multi-cellular assemblies. We focus on the single cell case and henceforth often drop the quotation marks so that morphogen refers to the morphogen-like action we consider.] A localized source for the morphogens along with degradation that occurs throughout the cell, can result in a steady-state concentration gradient of the morphogen. Proteins that associate with this morphogen may then also develop a concentration gradient. For example, in the spatial coordination of the spindle assembly, there is a spatial gradient of GTPase (guanosine triphosphatase) Ran that influences the nuclear localization signal (NLS)-containing protein that in turn determines the spatial organization of the microtubules [4, 5] . The polar positioning of the germline at the one-cell stage embryo of C. Elegans requires a spatial gradient of MEX-5 proteins [16] . This gradient of MEX-5 forms due to localized phosphorylation of the protein at the posterior side of the cell [29] [30] [31] .
To be more concrete, our analysis is done in the context of the gradient formation by MEX-5 protein during the division of the one-cell-stage C. Elegans embryo [29, 30] , although the analysis is generic and may apply to many molecular situations. In Sec. III we present an alternative mechanism, where a diffusing "morphogen" (that acts within a single cell) produced at a localized source is uniformly removed from the solution (effectively degraded) through its association with the protein of interest. In general, this association can either lower or raise the free energy of the protein. Morphogen "degradation" and diffusion results in a steady-state morphogen concentration profile within the single cell. The association of the morphogen with the more slowly diffusing protein then results in a protein gradient within the single cell. The model may be applicable to a wide variety of systems. The nature of coupling of the protein-morphogen interaction leads to two different scenarios whose solutions are respectively presented in Secs. IV and V. We discuss the consequences of our model and its predictions in Sec. VI.
II. DIFFERENTIAL DIFFUSION MODEL: MOTIVATION FOR ALTERNATIVE MECHANISM
We first consider the differential diffusion model for protein gradients within a single cell, as proposed in [15, 23] . This involves three species of the same protein that can be in three different states, A, B and C with concentrations c A , c B and c C respectively as schematically shown in Fig. 1(a) . In the gradient formation of MEX-5 protein at the one-cell-stage of C. Elegans embryo the amount of total protein is larger at the anterior side and the protein is phosphorylated at posterior end of the embryo. MEX-5 binds to larger molecules through RNA with a certain rate and in a manner that is uniform throughout the cell volume. When phosphorylated, the rate of binding to RNA (and hence to the larger molecules) is extremely small, we assume it zero for simplicity. We further simplify the picture through the assumption that binding of the dephosphorylated form of MEX-5 to RNA directly implies binding to the larger molecules ignoring the detailed mechanism of this process.
When bound to larger molecules, the MEX-5 large molecule complex has a very small diffusivity. In the absence of the detailed understanding of those binding (and unbinding) mechanism, we consider two limiting cases.
(1) Since MEX-5 large molecule complex has very small diffusivity, it doesn't reach the posterior cortex (the only FIG. 1: We consider two limiting cases of the differential diffusion model in the context of MEX-5 protein gradients within a single cell in C. Elegans. (a) Case 1: A system of three states of the same protein where A is the unphosphorylated free form, B is the phosphorylated form and C is the form when the protein is associated with a larger molecule, which can happen throughout the cell volume. A is phosphorylated at the boundary of the cell at x = 0. C has a very small diffusivity whereas the diffusivities of A and B are similar. Since the diffusivity of C is very small, it is not relevant whether C is modified by phosphorylation since the probability of C reaching the boundary where phosphorylation occurs is very small. The protein dissociates from the larger molecules with a certain rate and only those free MEX-5 proteins reach the boundary and become phosphorylated. We show that gradient formation in such a system cannot be explained by the differential diffusion models. (b) Case 2: A system of two states of the same protein: A with large diffusivity and B bound to a large molecule so that the complex has a small diffusivity. When B is phosphorylated at x = 0, the complex dissociates and B transforms to A. A transforms into B throughout the system since complex formation can occur stochastically in the entire bulk. Differential diffusion models can explain the gradient formation of the total protein concentration in this case. In both figures, x = L is the system boundary that prevents a flux of proteins outside the cell.
region where phosphorylation can occur) and remains dephosphorylated. However, MEX-5 stochastically dissociate from the larger molecule with some rate; this allows MEX-5 to diffuse so that it can reach the phosphorylation site and become phosphorylated as in Fig. 1 (a). In this case, phosphorylation does not change the diffusivity of the protein but dephosphorylation, which happens uniformly throughout the system allows the proteins to be associated with the larger molecules, and thus, changes the diffusivity. We show below that this scenario does not lead to MEX-5 gradient formation through the mechanism of differential diffusion. (2) Phosphorylation affects the complex of MEX-5 bound to the larger molecule and allows the MEX-5 to unbind from the larger molecule. The MEX-5 diffusivity then increases as in Fig. 1(b) . We show that this scenario can lead to MEX-5 gradient formation through the mechanism of differential diffusion as has been shown in [29] . An important conclusion of our paper is that although the differential diffusion mechanism does not apply in case (1) our model, presented in Sec. III, predicts a protein gradient even in this case.
We now analyze the differential diffusion model for case (1) , demonstrate that it cannot explain gradient formation and then discuss case (2) that can allow for gradi-ent formation. Within our description, state A is the ordinary form of the protein (MEX-5) that is phosphorylated (though it can be any other molecule as well) at the boundary at x = 0 with a rate k p , so that it is transformed to state B. In state A, the protein can associate with the larger molecules, uniformly distributed in the bulk of the cell and we denote the complex as state C that occurs with a rate k b ; the dissociation rate of C reverting to the large molecule and the protein in state A is k d . x = L is the cell boundary where we assume no-flux boundary conditions for all species of the proteins and complexes.
Case 1: Since the proteins are dephosphorylated uniformly throughout the system, we assume B converts to A with a ratek in the bulk of the cell. It is reasonable to assume that the change in diffusivity of the proteins due to phosphorylation is very small (much smaller than even a factor of 2) and the diffusivities of A and B should be similar. However, we first consider the general case and allow these diffusivities to be different and specialize later on. The diffusivities of A, B and C are denoted by D A , D B and D C respectively. The set of first order reactions that represent the scenario described here are:
where the first reaction in Eq. (1) occurs at the boundary x = 0 and affects the concentration profiles through boundary conditions, while the rest of the reactions take place in the bulk of the cell. We now have three equations describing the dynamics of the concentrations of the three states of the protein:
with the boundary condition for C being
since C is neither created nor degraded at either of the boundaries. The boundary conditions at x = 0 for A and B contain the results of phosphorylation that occur only there:
We now find the steady-state solution where the time derivatives are all zero. Adding Eqs. (2) , and taking a first integral, we obtain
where c 1 is an integration constant. Using the boundary conditions at x = 0 or x = L, we obtain c 1 = 0. Then,
We now use the reasonable assumption that D A ∼ D B = D, since phosphorylation cannot result in a significant (e.g., factor of 2) change in the diffusivity of the protein. When the protein associates with the large molecule, the diffusivity of the complex is much smaller, therefore, D c ≪ D. This can be seen in the context of MEX-5 proteins in the one-cell-stage of C. Elegans, [29, 30] . [30] shows that there is a third component with even shower diffusivity D C ∼ 0.07µm 2 /s. In these limits, we find that
Integrating over x and using the boundary conditions, we find that ∂(c A + C B )/∂x = 0 and we show below that the protein gradient in this limit is zero. Case 2: We recover case (2), identical with, the models of [15, 23] , using D C = 0 in Eqs. (2) in the steady state if we take state B as the state in which the proteins can bind to the large molecules, the complex, denoted by the concentration of B, has a significantly smaller diffusion constant than the isolated protein in state A, as schematically shown in Fig. 1 
with the boundary conditions given by Eq. (4). Since in model (2) the two diffusion constants for A and B are very different, the differential diffusion model does predict a steady gradient of total protein concentration in this case.
On the other hand, for case (1), if phosphorylation does not significantly change the protein diffusivity [23, 24] , and for complex of the protein with large molecules is such that D C ≈ 0, we obtain from Eq. (6) ∂c C /∂x ≈ 0 since ∂(c A + c B )/∂x ≈ 0, and therefore, ∂(c A + c B + c C )/∂x ≈ 0 with corrections of the order of the very small difference (D A −D B ) and D C . Thus, for this case, the differential diffusion model predicts an approximately zero gradient of the total protein concentration. However, as we show below, our model that involves the action of a morphogen-like molecule on the protein is independent of the diffusivities of the protein states and predicts a non-zero gradient of the total protein concentration for both cases. For the C. Elegans embryo, it is possible that the actual process is a combination of the two limiting cases we considered.
III. GRADIENT FORMATION THROUGH "MORPHOGEN" DIFFUSION
We now present our model that shows how a "morphogen" (that diffuses within a single cell) can interact with proteins to form both morphogen and protein FIG. 2: A schematic picture of gradient formation of protein via "morphogen" diffusion. The morphogen has a fixed flux at one end of the cell, at x = 0, and is degraded by association with the protein molecules throughout the bulk. In the steady state, the morphogen concentration has a steady-state profile. We predict here how the protein-morphogen interactions result in a protein concentration gradient.
steady-state gradients in biological systems. A similar idea coupling one steady-state, reaction-determined (morphogen) concentration profile to another species that reaches equilibrium (but on the scale of cell assemblies) was first considered by Dasbiswas, Alster and Safran in the context of a mechnobiological model for the coupling of long-range contractility (that reaches mechanical equilibrium) and diffusing biomolecules to show how the morphogen concentration profile can scale with the system size due to long-range mechanical coupling [22] . We present our model, where the morphogens have a steady-state profile but the proteins can reach thermodynamic -as opposed to mechanical -equilibrium, in general terms since the physics and predictions are generic in nature, but do discuss specific applications. Our model predicts protein gradient formation via the simplest possible non-linear term (quadratic in the concentration) in the effective diffusion-degradation equation for the morphogen. We note that since the proteins have no longrange coupling with each other, we do not find scaling of the protein concentration profile with the system size as was the case for the morphogen-contractility coupling in multi-cellular assemblies of Ref. [22] . Our focus here is on how protein gradients within single cells can be established and not on scaling with system size.
In our description, the "morphogen" acts as a signal within a single cell that establishes a gradient of protein at a certain stage of development (see Fig. 2 for a schematic picture). Such a morphogen, for example, may correspond to a phosphate (P O 3− 4 ) group in case of C. Elegans or to GTPase Ran in case of spindle formation in early embryo development (e.g. Xenopus). This morphogen is created at localized source that is expressed by imposing a flux-boundary condition; once secreted, the morphogen diffuses throughout the cell with diffusivity D. The diffusing morphogen locally associates throughout the cell volume, with the proteins of interest (assumed to be uniformly distributed before the morphogen is secreted), that eventually adjust their local concentration to that of the morphogen. This "adiabatic" approximation assumes that the morphogen diffuses quickly to attain its steady-state profile determined by the instantaneous protein concentration which changes slowly. The proteins eventually reach equilibrium as determined by minimization of the local protein free energy, including its interaction with the local concentration of the morphogen. Therefore, the diffusion-degradation equation, describing the dynamics of the free morphogen concentration, ψ(x, t) (in dimensionless units where the volume is scaled by the morphogen molecular volume), at position x and time t will be
where R 0 is the rate of local degradation that may include irreversible association of the morphogen with other molecules as well as biochemical degradation. The effective degradation term represented byΛ[c(x, t), ψ(x, t)] accounts for the interaction of the morphogen with the gradient-forming protein whose local concentration evolves much more slowly (than morphogen diffusion) with time.
At long times, the proteins reach local equilibrium via their interactions with the steadystate morphogen profile and we solve Eq. (7) in that limit where the protein concentration profile in equilibrium is denoted by c(x).
We focus on the cases where the morphogen-protein associations are irreversible and result in morphogen degradation. Therefore,Λ[c(x, t), ψ(x, t)] is proportional to the local protein concentration, c(x). However, there must be nonzero amount of morphogen for degradation, therefore,
In the cases we consider, the "morphogen" can be a phosphate group or an enzyme that diffuses quickly. The protein concentration profile is assumed to be uniform before the morphogen is secreted at one end of the cell (this can also be somwhere in the bulk of the cell, as in the case of spindle formation). The morphogen quickly reaches its steady-state profile. The proteins, which diffuse more slowly, interact with this steady-state profile and then locally diffuse to adjust their own concentration profile to adjust to the local morphogen concentration. The proteins eventually reach their local, equilibrium concentration profile, c(x), that includes their interactions with the morphogen. We consider the protein concentration to be dilute and write the protein free energy per unit volume, f , as:
where α is the strength of protein-morphogen interaction in units of k B T , the Boltzmann constant times temperature, and µ is the chemical potential. Here we allow α to be either + or −. Positive α decreases the protein free energy and such processes are always allowed. Negative values of α increase the protein free energy and such processes are rare, but still allowed in equilibrium due to entropic effects. Biological systems are generally out of equilibrium, so that processes that can increase the free energy are still allowed. In this case, the morphogen will antagonize the protein. The two signs of the interaction strength α lead to two different situations that we solve separately. We call the situation where α > 0, the synergistic protein-morphogen interaction and the situation where α < 0, the antagonistic protein-morphogen interaction, hereafter denoted as synergistic and antagonistic respectively.
Minimizing the free energy, Eq. (8), with respect to c(x), we obtain
We can, in principle, solve for any values of α, but it is more instructive (but only for mathematical convenience) to consider the small interaction case, which is the focus in this paper . In this limit we expand the exponential and obtain c(x) = e µ (1+αψ). Using this, we obtain from Eq. (7), for the synergistic scenario
where A = R 0 +Āe µ and B =Āe µ α. For the antagonistic scenario, when α < 0, we obtain
with B =Āe µ |α|. We see from Eq. (9) that the protein concentration profile follows the morphogen concentration for the synergistic interaction, whereas the antagonistic scenario predicts a protein concentration profile that is complementary to that of the morphogen concentration.
When α ≈ 0, e µ is approximately the average protein concentration c 0 . For non-zero α, µ ≈ ln c 0 + O(1/L) where L is the 1d size of the system. Considering L very large with respect to the molecular interactions that govern the morphogen concentration profile, we obtain c 0 ≈ e µ and therefore
We set the time-derivatives of the morphogen concentration ψ in Eqs. (10) and (11) to zero in the steadystate and also consider the equilibrium protein concentration profile. To complete the description of the models, we must account for the two boundary conditions on ψ(x). Since the morphogen is secreted at the x = 0 edge of the cell with a fixed flux, one boundary condition is dψ(x, t)/dx = −j 0 where j 0 is the morphogen flux. The other boundary condition is that the morphogen flux vanishes at the other end of the cell, thus, dψ(x, t)/dx = 0. For simplicity, we take the cell size L → ∞ (relative to molecular scales); however, this doesn't affect the results if L is much greater than the typical molecular scales where the concentration gradients are significant.
IV. SYNERGISTIC PROTEIN-"MORPHOGEN" INTERACTIONS
We first consider the synergistic situation where the protein energy is decreased by association with the "morphogen" (α > 0), with the equation of motion for the morphogen density in an infinite, one-dimensional system given by:
with the boundary condition of a fixed flux j 0 at x = 0 and zero flux at x = L, where we focus on the limit where L → ∞, relative to the molecular length scales of the gradients. We write the steady state solution of
and show in the SM that this steady-state solution is stable to small perturbations of the profile. To simplify the discussion, we define φ 0 = φ/j 0 andB = j 0 B/A and redefine x → √ Ax and t → At. We also measure j 0 in units of √ A and set D to unity. (Note that these redefinitions do not affect the nature of the solution; they can be reversed at the end to give dimensional times, distances and fluxes.) After a first integration and taking L → ∞, we obtain (see SM for details)
Taking the + sign (− sign leads to the same results) and integrating once more we obtain the steady-state morphogen profile:
where k is an integration constant determined from the boundary condition. With the previous normalizations, we can now write the boundary condition at x = 0 as dφ 0 /dx| x=0 = −1, so that
The parameterB that determines k is proportional to the product of the morphogen flux, j 0 , and the morphogenprotein interaction, α. Eq. (17) has only one real solution for k and in the SM we perform a stability analysis to show this solution is stable. Once we obtain the solution for φ 0 (x), which is the steady state solution for ψ(x, t), we can find the local concentration of the protein from Eq. (9). Since c 0 ≈ ln µ with a correction of the order of 1/L is a constant, c(x)/c 0 determines the profile of the total protein concentration. We show the profiles for c(x)/c 0 for different values ofB in Fig. 3 and the corresponding profiles for the morphogen concentration φ 0 (x) in the inset. Note that we have rescaled the spatial coordinate x by 1/ √ A. The curves go to zero more slowly as the parameterB decreases. Thus, the cell can reduceB (through reducing the flux, for example) to keep the protein concentration significant over larger length scales. On the other hand, larger values ofB result in sharper spatial decay of the protein concentration. Thus,B (which includes both the protein-morphogen interaction and the flux in its definition) is a single parameter that controls the protein concentration gradient.
V. ANTAGONISTIC PROTEIN-"MORPHOGEN" INTERACTIONS
We now consider the antagonistic situation where the protein energy increases by association with the "morphogen" (α < 0), where the equation of motion for the morphogen density is governed by before, we obtain the solution for the steady state morphogen profile as (see SM for more detail)
where k is the integration constant that is determined through the boundary condition at x = 0:
Since tanh k ranges from 0 to 1, Eq. (20) imposes a constraint onB. Using the maximum of the left hand side of Eq. (20), we find that in order to have a real solution for the integration constant k, the parameter B ≤ 1/ √ 3. IfB is greater than this value, there is no steady-state solution. From Fig. 4 we see that for certain values ofB, we have two real solutions for k. From the stability analysis, we find that the solution corresponding to one of these values of k is stable, whereas the other is unstable and dynamically evolves when perturbed to the stable solution. IfBφ 0 (x = 0) is greater than unity, the solution is unstable; otherwise it is stable (see SM). The third solution of Eq. (20) gives a complex value for k that leads to negative values for φ 0 (x). Since φ 0 (x) is a concentration, it must be positive so that we do not consider this as a physical solution.
We plot the protein concentration profile c(x)/c 0 , Eq. (12), in Fig. 5 for different values ofB as shown in the figure and the morphogen concentration for the corresponding parameters in the inset. Since α = −0.2 is negative, in this antagonistic case, the protein concentration profile is complimentary to that of the morphogen profile; the proteins tend to avoid the morphogen. The phosphorylation process of MEX-5 protein in the one-cell stage of C. Inset: Solution for the "morphogen" concentration for the corresponding values of the parameters. We see that the gradient of protein concentration is complimentary to that of the morphogen concentration, which is expected since the morphogen increases the protein energy in this antagonistic case, so the protein avoids the morphogen.
Elegans can be taken as an example of this case. In the unphosphorylated state, MEX-5 proteins associate with larger molecules through RNA. When phosphorylated, MEX-5 dissociates from RNA leading to a local entropy increase; the proteins thus tend to avoid the phosphate molecules.
VI. DISCUSSION
We have shown that protein gradients in single cells can be established from an initially, uniform protein distribution via their interactions with a diffusing molecule whose action is similar to that of morphogen produced at a localized source; both the protein and "morphogen" dynamics are coupled. We have rescaled the steady state morphogen concentration by its flux and presented the results in terms of a single parameterB. We find that the particular combination,B = j 0 B/A, which depends on the flux j 0 , the linear and quadratic degradation rates A and B, is the single parameter that controls gradient formation. This parametrization is advantageous since the gradient of the morphogen (and the proteins) is the important parameter rather than their absolute values at the source located at x = 0. The cell can therefore change the protein gradient via changes in the morphogen flux. For example, Figs. 3 and 5 show that the profiles for the morphogen and the protein strongly depend onB and cells can adjust this parameter in order to realize different profiles for the protein concentration.
In the cases of interest here, the proteins are significantly larger and thus diffuse more slowly than the morphogens. Thus, the morphogens can reach their steady-state profile adiabatically with respect to the local and slowly evolving, instantaneous protein concentration. That means that the steady-state morphogen profile is a function of the local protein concentration c(x, t) which varies only slowly with time so that on relatively short time scales compared to the protein diffusional dynamics, the morphogens attain their steady state which depends parametrically on c(x, t). Before the morphogens are secreted, the proteins are uniformly distributed in the cell volume and diffuse only locally to adjust to the morphogen concentration. We focus on time scales that are long compared with both the morphogen and protein diffusional time scales and determine the local protein concentration in equilibrium. Since the proteins interact with the morphogens, minimization of their free energy involves the local morphogen concentration which, in turn, depends on the local protein concentration. At very long times, one therefore solves the steady-state profiles for the morphogen as coupled to the equilibrium protein concentration profile. In the particular case of MEX-5 gradient formation in one-cell stage of C. Elegans, the MEX-5 protein concentration starts from a uniform concentration at pronuclear stage and evolves to a stable protein gradient at nuclear envelope breakdown (NEBD). Our calculation in this work applies for the protein-gradient at this final NEBD stage [29] .
Diffusion-degradation models with non-linear degradation terms appear in many different systems in biological physics, so their quantitative analysis is important. In Ref. [22] such a model, that corresponds to the synergistic scenario in this work, was obtained when the longrange nature of mechanical contractility within a cell assembly was coupled to the morphogen degradation (or trapping within the cytoskeleton). In that case, the sign of the nonlinear degradation term depends on the nature of the morphogen cytoskeletal mechanical coupling and, with the appropriate coupling, can also correspond to the antagonistic scenario studied above [32] . The stability analysis that we have detailed in the SM also tells us about any possibility of pattern formation within the mechanogen model. We have seen that the morphogen profile is completely stable for synergistic interactions. For antagonistic interactions, there are two possible solutions one of which is stable while the other is unstable. When perturbed, the unstable solution dynamically evolves to the stable one. This shows that the basic version of the mechanogen model will not be unstable to pattern formation, for which we need further ingredients.
There can be a number of different scenarios by which the morphogen antagonizes the protein. For example, association of the morphogen molecule may increase the total free energy of the protein. Association of the morphogen with the protein may release other molecules associated with that protein. A similar scenario happens in the one-cell-stage C Elegans embryo where phosphoryla-tion of the MEX-5, when it is associated with mRNA, may dissociate the RNA molecule. In this case, the quadratic term in the antagonistic scenario -that effectively results in release of additional morphogen to the solution -cannot be larger than the linear degradation term, since only via degradation can the morphogens be removed from solution to associate with the proteins. In our theory, this is reflected in the finding thatB must be less than 1/ √ 3 if steady-state, morphogen and protein gradients are to be maintained.
Our model predicts protein gradient formation via the simplest possible non-linear term (quadratic in the concentration) in the effective diffusion-degradation equation for the morphogen. We have presented our theory for irreversible protein-morphogen interaction. The relative irreversibility is connected to the relation of the various rate constants. For a large value of R 0 , the proteinindependent rate of morphogen degradation, the term Λ[c(x, t), ψ(x, t)] in Eq. (7) is negligible compared to the local degradation term. In that case, the parameter A in our theory is very large and the coefficient of the quadratic term,B is small, as can be seen from the scalings we use. This means the morphogen degradation is dominated by the linear degradation term. Even if the morphogen gradient is very large, the resulting protein gradient that depends on the value of the coupling alpha (Eq. 12), may not be as large, depending on the value of α.
Ref. [29] shows that a cortical phosphorylation (localized source of phosphorylation at the boundary of the cell) alone is not capable of capturing the experimen-tal results for the gradient formation of MEX-5 proteins and one must look at the cytoplasmic distribution of the phosphate molecules. Our theory allows for a cytoplasmic morphogen steady-state profile (e.g., the phosphate molecules in C. Elgans) as well as the cytoplasmic protein gradient; this offers a more complete scenario even for situations where the differential-diffusion mechanism may apply. The scenario focused upon in our theory is independent of the change of the protein diffusivity upon interaction, which is the key feature of differential diffusion models [15, 23] . It is possible that the change in free energy also modifies the diffusivity, but this can occur in other ways as well. The ideal systems to test our ideas may be found in systems with intracellular protein gradients where association with the morphogen changes the protein diffusivity only negligibly. Of course, in any given system, it is possible that the "morphogen" and the differential-diffusion mechanisms both operate. However, the "morphogen" scenario we have treated allows for cells to control their protein gradients by localized secretion of the morphogen-like molecules.
Supplemental Material: Protein gradients in single cells induced by "morphogen"-like diffusion Appendix: S1. STABILITY ANALYSIS FOR SYNERGISTIC SCENARIO
The steady-state "morphogen" concentration, φ(x), scaled with the flux j 0 is φ 0 (x) = φ(x)/j 0 . After redefining x → √ Ax, t → At andB = j 0 B/A, we obtain the equation of motion for φ 0 as
Multiplying Eq. (S1) with dφ 0 /dx and integrating once, we obtain
where c 1 is the integration constant. As x → ∞, both φ 0 and its derivative must vanish so that we find c 1 = 0. We then write:
We now examine the stability of the solution of Eq. (S3), as given by Eq. (16) . For this we perform a linear stability analysis of ψ(x, t) = φ 0 (x) + δψ(x, t), where δψ(x, t) is a small perturbation to φ 0 (x). Assuming that δψ is small, and keeping terms up to linear order, we obtain from Eq. (13) ,
with the boundary conditions of no-flux for δψ(x, t) at both boundaries since the flux boundary conditions are already satisfied the steady-state solution φ 0 (x). We write δψ(x, t) = δψ(x)e ωt ; as discussed in Sec. Appendix: S3, a positive value of ω signifies that the steady state solution is unstable while negative ω indicates a stable solution. Then, from Eq. (S4), we obtain
where k is the integration constant obtained from Eq. (17) . We see that there is only one real solution of k and two imaginary solutions for a particular value ofB. The imaginary values of k leads to negative values of φ 0 (x); since φ 0 (x) is a concentration and must be positive, we reject these values of k and use the real value only. We definex = x/2 + k and write the above equation as
Defining x ′ = cothx, we obtain from the above equation:
with ν = 3 and µ 2 = 4(1 + ω). Eq. (S7) is the standard equation for the associated Legendre function and obtain the solutions in terms of those functions, P µ ν (x ′ ) and Q µ ν (x ′ ) [33] . Satisfying the no-flux boundary condition at x = 0, we obtain the value for µ. We find no real solution for µ, but there are imaginary values of µ that satisfy the boundary condition. This means ω must be negative and that the steady state solution, Eq. (16) is stable. We have verified these analytical results via numerical calculations.
Appendix: S2. STABILITY ANALYSIS FOR ANTAGONISTIC SCENARIO
Using the scaled variables, as discussed in Sec. V, we obtain the equation for the steady-state "morphogen" concentration as
whereB = j 0 B/A and φ 0 (x) = φ(x)/j 0 with j 0 is the morphogen flux at its source at x = 0. Multiplying the above equation by dφ 0 (x)/dx and integrating yields
where c 1 is the integration constant. Both φ 0 and its derivative must vanish at x → ∞ so that we obtain c 1 = 0. Then,
Both positive and negative signs lead to the same solution which we find is:
where k is the integration constant, as discussed in Sec. V.
To examine the stability of the steady-state solution, we analyze the effects of perturbations to φ 0 . We write ψ(x, t) = φ 0 (x) + δψ(x, t) where we assume that δψ(x, t) is small. Then, from Eq. (18), up to linear order in δψ(x, t), we obtain
with no-flux of δψ(x, t) (i.e., dδψ/dx = 0) at x = 0, since the flux boundary condition has already been satisfied by the steady state soluiton , φ 0 . Similarly, δψ must vanish as x → ∞. For the stability analysis we write δψ(x, t) = δψ(x)e ωt and find the value of ω for which the solution for δψ(x, t) satisfies the boundary conditions.
Positive ω means the solution is unstable and vice versa (see Sec. Appendix: S3). We then write:
(S13) Definingx = x/2 + k we obtain from the above equation
We define x ′ = tanhx, and obtain
where ν = 3 and µ 2 = 4(1 + ω). Again, this is the standard associated Legendre equation whose solutions are: P µ ν (x ′ ) and Q µ ν (x ′ ) [33] . The general solution is the linear combination of these two functions:
where we have set the overall amplitude of the perturbation to unity (so that D is the ratio of the two Legendre functions), since the overall amplitude is not determined by the boundary conditions. We have seen that for µ ≥ 3 Eq. (S15) has no soluiton that satisfy the boundary condition of no flux at x = 0. We note that x ′ → 1 as x → ∞ and x ′ = tanh k when x = 0. To determine the constant D in Eq. (S16) we use the boundary condition δψ(x ′ ) → 0 as x ′ → 1 − (approaching from left where x < 1). We first obtain the expansions for the associated Legendre functions for x ′ → 1 − as and obtain D as
.
(S19)
Note that this result is applicable for non-integer µ.
For each value ofB we have two values of k [see Eq. (20) ]. For each value of k, we obtain a solution for µ by requiring that the perturbation satisfy the no-flux boundary condition at x = 0. If the value of µ is larger than 2, we find that the eigenvalue ω is positive since 4(1 + ω) = µ 2 , so that the corresponding solution is unstable. On the other hand, if µ < 2, then ω is negative and the corresponding solution is stable. We find that for fixes values ofB < 1/ √ 3, one of the two solutions corresponding to the two real values of k is stable and the other one is unstable and dynamically evolves to the stable solution.
We illustrate this point with an example.B must be less than 1/ √ 3 for a physical solution and we choosē B = 0.42. We numerically solve Eq. (18) with ψ(x, t) = φ 0 (x) + Gδψ(x, t) where G is a small amplitude of the perturbation. For the numerical solution, we take 0 ≤ x ≤ 20 and 0 ≤ t ≤ 400 and start with the initial condition given by the two solutions for φ 0 (x) and δψ(x, t), Eqs. (S11) and (S16) respectively. ForB = 0.42, we obtain the two values of k as k 1 = 0.32 and k 2 = 1.12. For k 1 we obtain µ = 2.58 and for k 2 we obtain µ = 1.22. Therefore, from our analysis, the solution corresponding to k 2 is stable whereas the solution corresponding to k 1 is unstable and evolves to the solution corresponding to k 2 with time. This is exactly what we observe in the numerical solution as illustrated in Fig. S1 .
What are the differences between the two solutions when their shapes look so similar, while one is stable and the other unstable? For the example that we have considered here, if we integrate both solutions over x we find a total scaled amount of morphogen equal to 4.93 for the solution corresponding to k 1 and 1.37 for the solution corresponding to k 2 . Therefore, we see that when the amount of morphogen is large, the solution becomes unstable and dynamically evolves to the one that corresponds to smaller amount of morphogen in steady-state. We can understand this stability in another way. Let us look at the last two terms of Eq. (S8) where the first one reduces the rate of morphogen accumulation, while the last one increases this rate. φ 0 (x) has the maximum at x = 0. IfBφ 0 (x = 0) is greater than unity, the accumulation term dominates the degradation term and the concentration profile is unstable; otherwise, it is stable. For the example we have considered, we obtain Bφ 0 (x = 0) = 1.36 for the solution corresponding to k 1 andBφ 0 (x = 0) = 0.52 for the solution corresponding to k 2 . Thus, the former solution is unstable and the latter is stable, similar to what we conclude from more detailed numerical and analytical analysis.
Appendix: S3. STABILITY ANALYSIS IN TERMS OF VARIATION OF A FUNCTIONAL
For concreteness, we consider the antagonistic scenario where the equation of motion for the "morphogen" density is given by ∂ψ(x, t) ∂t = D∇ 2 ψ(x, t) − Aψ(x, t) + Bψ 2 (x, t). (S20)
It is well known [34] that systems near thermodynamic equilibrium have dynamics that can often be related to variations of their free energy. Though the biological systems we consider here are, by their nature, far from equilibrium, in the cases treated here, we can still define a functional of the morphogen concentration, F whose variation governs the dynamics. This functional is not to be associated with any free energy since it is determined by various reaction processes. We thus write:
∂ψ(x, t) ∂x
and the dynamics is obtained from the equation
It is instructive to understand the stability analysis, by considering Eq. (S21) along with Eq. (S22) that gives rise to the dynamical equation that governs the morphogen. We now consider fluctuations away from the steady-state morphogen concentration profile and write ψ(x, t) = φ 0 (x) + δψ(x, t) where δψ(x, t) is small and expand F up to quadratic order in δψ(x, t):
Integrating by parts, and assuming that the perturbation vanishes at the boundaries, we obtain
The first part of the integrand is the equation whose zero determines the steady-state concentration profile φ 0 (x) of Eq. (S20); so this term vanishes. If we write δψ(x, t) = δψ(x)e ωt , the second part can be identified, with the help of Eq. (S12), as −ωδψ(x, t)/2. Then we obtain δF = −ω dx 1 2 δψ 2 (x, t).
This equation shows that if ω is positive, any perturbation decreases the functional and the solution is unstable.
On the other hand, if ω is negative, the perturbation δψ increases the functional, therefore the system rejects the perturbation and the steady state solution is stable.
